GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » Forward PE Ratio

Komipharm International Co (XKRX:041960) Forward PE Ratio : 0.00 (As of Jul. 24, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Komipharm International Co Forward PE Ratio?

Komipharm International Co's Forward PE Ratio for today is 0.00.

Komipharm International Co's PE Ratio without NRI for today is 69.93.

Komipharm International Co's PE Ratio (TTM) for today is 29.88.


Komipharm International Co Forward PE Ratio Historical Data

The historical data trend for Komipharm International Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Komipharm International Co Forward PE Ratio Chart

Komipharm International Co Annual Data
Trend
Forward PE Ratio

Komipharm International Co Quarterly Data
Forward PE Ratio

Competitive Comparison of Komipharm International Co's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Komipharm International Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Komipharm International Co's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Komipharm International Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Komipharm International Co's Forward PE Ratio falls into.


;
;

Komipharm International Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Komipharm International Co  (XKRX:041960) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Komipharm International Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Komipharm International Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Komipharm International Co Business Description

Traded in Other Exchanges
N/A
Address
1236-6 Jungwang-Dong, Sihung, Gyeonggi, KOR, 429-450
Komipharm International Co Ltd is involved in the healthcare sector based in Korea. Its core business includes development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The company produces its products under two divisions: veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle. The other division is made up of veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis and swine erysipelas.

Komipharm International Co Headlines

No Headlines